Association of lncRNA LINC01173 Expression with Vitamin-D and Vitamin B12 Level Among Type 2 Diabetes Patients

References

• IDF Diabetes Atlas, 9th edn. Brussels, and Belgium, “IDF Diabetes Atlas, 9th edn”; 2019. Available from: https://www.diabetesatlas.org. Accessed August 5, 2022.
   Google Scholar
• Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50. doi:10.1016/j.diabres.2017.03.024
   PubMed Web of Science ®Google Scholar
• Ruan Y, Lin N, Ma Q, et al. Circulating LncRNAs analysis in cases with type 2 diabetes reveals novel genes influencing glucose metabolism and Islet β-cell function. CPB. 2018;46(1):335–350.
   Google Scholar
• Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136(4):629–641. doi:10.1016/j.cell.2009.02.006
   PubMed Web of Science ®Google Scholar
• Chen Z. Progress and prospects of long noncoding RNAs in lipid homeostasis. Mol Metab. 2016;5(3):164–170. doi:10.1016/j.molmet.2015.12.003
   PubMed Web of Science ®Google Scholar
• Akerman I, Tu Z, Beucher A, et al. Human pancreatic β cell lncRNAs control cell-specific regulatory networks. Cell Metab. 2017;25(2):400–411. doi:10.1016/j.cmet.2016.11.016
   PubMed Web of Science ®Google Scholar
• Il Jang W, Kim M-S, Kang SH, et al. Association between metformin use and mortality in cases with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in Korea. Oncotarget. 2017;8(6):9587–9596. doi:10.18632/oncotarget.14525
   Google Scholar
• He X, Ou C, Xiao Y, Han Q, Li H, Zhou S. LncRNAs: key players and novel insights into diabetes mellitus. Oncotarget. 2017;8(41):71325–71341. doi:10.18632/oncotarget.19921
   PubMedGoogle Scholar
• Lu W, Huang SY, Su L, Zhao BX, Miao JY. Long noncoding RNA LOC100129973 suppresses apoptosis by targeting miR-4707-5p and miR-4767 in vascular endothelial cells. Sci Rep. 2016;6(1):21620. doi:10.1038/srep21620
   Web of Science ®Google Scholar
• Liu X, Xiao Z-D, Han L, et al. LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress. Nat Cell Biol. 2016;18(4):431–442. doi:10.1038/ncb3328
   PubMed Web of Science ®Google Scholar
• Alvarez-Dominguez JR, Bai Z, Xu D, et al. De Novo reconstruction of adipose tissue transcriptomes reveals long non-coding RNA regulators of brown adipocyte development. Cell Metab. 2015;21(5):764–776. doi:10.1016/j.cmet.2015.04.003
   PubMed Web of Science ®Google Scholar
• Qi M, Zhou Q, Zeng W, et al. Analysis of long non-coding RNA expression of lymphatic endothelial cells in response to type 2 diabetes. CPB. 2017;41(2):466–474.
   Google Scholar
• Luo G, Liu D, Huang C, et al. LncRNA GAS5 Inhibits Cellular Proliferation by Targeting P27Kip1. Mol Cancer Res. 2017;15(7):789–799. doi:10.1158/1541-7786.MCR-16-0331
   Web of Science ®Google Scholar
• Jin F, Wang N, Zhu Y, You L, Wang L, De W, Tang W. Downregulation of long noncoding RNA Gas5 affects cell cycle and insulin secretion in mouse pancreatic β cells. CPB. 2017;43(5):2062–2073.
   Google Scholar
• Senée V, Chelala C, Duchatelet S, et al. Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat Genet. 2006;38(6):682–687. doi:10.1038/ng1802
   PubMed Web of Science ®Google Scholar
• Tan L, Yang Y, Shao Y, Zhang H, Guo J. Plasma lncRNA‑GACAT2 is a valuable marker for the screening of gastric cancer. Oncol Lett. 2016;12(6):4845–4849. doi:10.3892/ol.2016.5297
   PubMed Web of Science ®Google Scholar
• Terracciano D, Ferro M, Terreri S, et al. Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers. Transl Res. 2017;184:108–117. doi:10.1016/j.trsl.2017.03.005
   PubMed Web of Science ®Google Scholar
• Shen X, Zhang Y, Wu X, et al. Upregulated lncRNA-PCAT1 is closely related to clinical diagnosis of multiple myeloma as a predictive biomarker in serum. Cancer Biomark. 2017;18(3):257–263. doi:10.3233/CBM-160158
   PubMed Web of Science ®Google Scholar
• Albannawi G, Alsaif S, Alsaif G, et al. Vitamin D deficiency among type 2 diabetes patients in Saudi Arabia: a systematic review. Int J Diabetes Dev Ctries. 2020;3(12)197–203.
   Google Scholar
• Al Dawish MA, Robert AA, Braham R, et al. Diabetes Mellitus in Saudi Arabia: a review of the recent literature. Curr Diabetes Rev. 2016;12(4):359–368. doi:10.2174/1573399811666150724095130
   PubMedGoogle Scholar
• Briani C, Dalla Torre C, Citton V, et al. Cobalamin deficiency: clinical picture and radiological findings. Nutrients. 2013;5(11):4521–4539. doi:10.3390/nu5114521
   PubMed Web of Science ®Google Scholar
• Wang D, Zhai JX, Liu DW. Serum folate, vitamin B12 levels and diabetic peripheral neuropathy in type 2 diabetes: a meta-analysis. Mol Cell Endocrinol. 2017;443:72–79. doi:10.1016/j.mce.2017.01.006
   Web of Science ®Google Scholar
• Verma AK, Aladel A, Dabeer S, et al. Clinical Importance of FNDC-5 and selectin-E mRNA expression among type 2 diabetics with and without obesity, diabetes, metabolic syndrome and obesity. Targets Ther. 2022;15:1011.
   Google Scholar
• Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22(4):477–501. doi:10.1210/edrv.22.4.0437
   PubMed Web of Science ®Google Scholar
• Finkelstein JL, Layden AJ, Stover PJ. Vitamin B-12 and Perinatal Health. Adv Nutr. 2015;6(5):552–563. doi:10.3945/an.115.008201
   PubMed Web of Science ®Google Scholar
• Hu W, Ding Y, Wang S, Xu L, Yu H. The construction and analysis of the aberrant lncRNA-miRNA-mRNA network in adipose tissue from type 2 diabetes individuals with obesity. J Diabetes Res. 2020;2020:3980742. doi:10.1155/2020/3980742
   PubMed Web of Science ®Google Scholar
• Abdulle LE, Hao JL, Pant OP, et al. MALAT1 as a diagnostic and therapeutic target in diabetes-related complications: a promising long-noncoding RNA. Int J Med Sci. 2019;16(4):548–555. doi:10.7150/ijms.30097
   PubMed Web of Science ®Google Scholar
• Amir H, Khan MA, Feroz S, et al. CARLo-7-A plausible biomarker for bladder cancer. Int J Exp Pathol. 2019;100(1):25–31. doi:10.1111/iep.12305
   Web of Science ®Google Scholar
• Lee WC, Mokhtar SS, Munisamy S, Yahaya S, Rasool AHG. Vitamin D status and oxidative stress in diabetes mellitus. Cell Mol Biol. 2018;64(7):60–69. doi:10.14715/cmb/2018.64.7.11
   Web of Science ®Google Scholar
• Mirhosseini N, Vatanparast H, Mazidi M, Kimball SM. Vitamin D supplementation, glycemic control, and insulin resistance in prediabetics: a meta-analysis. J Endocr Soc. 2018;2(7):687–709. doi:10.1210/js.2017-00472
   PubMed Web of Science ®Google Scholar
• Elmarakby AA, Sullivan JC. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc Ther. 2012;30(1):49–59. doi:10.1111/j.1755-5922.2010.00218.x
   PubMed Web of Science ®Google Scholar
• Szymczak-Pajor I, Drzewoski J, Śliwińska A. The molecular mechanisms by which vitamin D prevents insulin resistance and associated disorders. Int J Mol Sci. 2020;21(18):6644. doi:10.3390/ijms21186644
   PubMed Web of Science ®Google Scholar
• Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr. 2011;94(2):486–494. doi:10.3945/ajcn.111.011684
   PubMed Web of Science ®Google Scholar
• Zakhary CM, Rushdi H, Hamdan JA, et al. Protective role of vitamin D therapy in diabetes mellitus type II. Cureus. 2021;13(8):e17317. doi:10.7759/cureus.17317
   Web of Science ®Google Scholar
• Mathieu C, Badenhoop K. Vitamin D and type 1 diabetes mellitus: state of the art. Trends Endocrinol Metab. 2005;16(6):261–266. doi:10.1016/j.tem.2005.06.004
   Web of Science ®Google Scholar